Pharmaceuticals, Biotechnology and Life Sciences
International top-level speakers and panelists DUSSELDORF, Germany–(BUSINESS WIRE)–The countdown is on for DxPx Conference, which will start on November 18,…
Revenues of $45.6 Billion for the Fourth Quarter, a 5.4 Percent Increase Year-Over-Year Fourth Quarter GAAP Diluted EPS of $0.63…
– Data support differentiation of voclosporin as a potential best-in-class CNI – VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH /…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic CD4+ Lymphocytopenia – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Idiopathic CD4+ Lymphocytopenia…
Entrome SA, a clinical-stage biopharmaceutical company will work with Memorial Sloan Kettering Cancer Center (MSK) in New York City to evaluate the potential of gut microbiome-derived antigens for development as cancer immunotherapies.
SUZHOU, China–(BUSINESS WIRE)–MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence – a leading genomic medicine company – today announced an agreement…
− New England Journal of Medicine publishes primary endpoint analysis from ongoing Phase 3 study of Takeda’s dengue vaccine candidate…
First patient dosed with UCARTCS1 in MELANI-01 Phase 1 dose-escalation clinical trial for Relapsed/Refractory Multiple Myeloma Patient screening ongoing with…
-Phase 3 development program aligned with FDA feedback, supporting development path to BLA -Pivotal Phase 3 clinical efficacy trial planned…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…